ES2178037T3 - Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que los contienen. - Google Patents

Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que los contienen.

Info

Publication number
ES2178037T3
ES2178037T3 ES97952998T ES97952998T ES2178037T3 ES 2178037 T3 ES2178037 T3 ES 2178037T3 ES 97952998 T ES97952998 T ES 97952998T ES 97952998 T ES97952998 T ES 97952998T ES 2178037 T3 ES2178037 T3 ES 2178037T3
Authority
ES
Spain
Prior art keywords
contain
preparation
pharmaceutical compositions
cyclosporine derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97952998T
Other languages
English (en)
Inventor
Jean-Claude Barriere
Georges Bashiardes
Jean-Christophe Carry
Michel Evers
Bruno Filoche
Jean-Pierre Leconte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2178037T3 publication Critical patent/ES2178037T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

DERIVADOS DE CICLOSPORINA CARACTERIZADOS PORQUE RESPONDEN A LA FORMULA GENERAL (I) EN LA QUE ALK ES ALQUILENO 2 A 6 C EN CADENA RECTA O RAMIFICADA O CICLOALQUILENO QUE CONTIENEN ENTRE 3 Y 6 C Y R ES O BIEN: COOH O ALQUILOXICARBONILO, O BIEN NR SUB,1 R 2 PARA LE CUAL R 1 Y R 2 IDENTICOS O DIFE RENTES SON H, O ALQUILO, ALCENILO (2 A 4 C), CICLOALQUILO (3 A 6 C), FENILO OPCIONALMENTE SUSTITUIDO (POR HALOGENO, ALQUILOXI, ALQUILOXICARBONILO, AMINO, ALQUILAMINO O DIALQUILAMINO), O SON RADICALES BENCILO O HETEROCICLO SATURADO O INSATURADO QUE CONTIENEN ENTRE 5 Y 6 ESLABONES Y ENTRE 1 Y 3 HETEROATOMOS, O PARA EL CUAL R 1 Y R 2 FORMAN CON EL ATOMO DE NITROGENO AL QUE ESTAN UNIDOS UN HETEROCICLO QUE CONTIENE ENTRE 4 Y 6 ESLABONES QUE PUEDEN CONTENER OTRO HETEROATOMO ELEGIDO ENTRE N, O O S Y OPCIONALMENTE SUSTITUIDO POR ALQUILO, FENILO O BENCILO, O BIEN UN RADICAL DE FORMULA GENERAL (I'') PARA EL CUAL R 1 Y R 2 SE DEFINEN COMO ANTERIORMENTE, R 3 Y H O AL QUILO Y N ES UN NUMERO ENTERO DE ENTRE 2 Y 4, SIENDO LAS PARTES O RADICALES ALQUILO DEFINIDOS ANTERIORMENTE RECTOS O RAMIFICADOS Y CONTENIENDO ENTRE 1 Y 4 C, ASI COMO SUS SALES FARMACEUTICAMENTE ACEPTABLES CUANDO EXISTEN. ESTOS NUEVOS PRODUCTOS SON DE UTILIDAD, SOBRE TODO, PARA EL TRATAMIENTO Y/O LA PROFILAXIS DE LAS INFECCIONES CON RETROVIRUS.
ES97952998T 1996-12-24 1997-12-23 Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que los contienen. Expired - Lifetime ES2178037T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615956A FR2757522B1 (fr) 1996-12-24 1996-12-24 Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ES2178037T3 true ES2178037T3 (es) 2002-12-16

Family

ID=9499089

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97952998T Expired - Lifetime ES2178037T3 (es) 1996-12-24 1997-12-23 Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que los contienen.

Country Status (14)

Country Link
US (1) US5965527A (es)
EP (1) EP0948527B1 (es)
JP (1) JP4172822B2 (es)
AT (1) ATE218580T1 (es)
AU (1) AU5669298A (es)
DE (1) DE69713148D1 (es)
DK (1) DK0948527T3 (es)
ES (1) ES2178037T3 (es)
FR (1) FR2757522B1 (es)
MA (1) MA26459A1 (es)
PT (1) PT948527E (es)
TN (1) TNSN97211A1 (es)
WO (1) WO1998028329A1 (es)
ZA (1) ZA9711606B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030220234A1 (en) 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
ES2212583T3 (es) * 1998-06-12 2004-07-16 C-Chem Ag Nuevas ciclosporinas.
PT1091975E (pt) 1998-07-01 2006-05-31 Debiopharm Sa Nova ciclosporina com um perfil de actividade melhorado
US6254860B1 (en) 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
WO2003033526A2 (en) 2001-10-19 2003-04-24 Isotechnika Inc. Synthesis of cyclosporin analogs
EP2116228A1 (en) * 2001-10-19 2009-11-11 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
KR20040039622A (ko) * 2002-11-04 2004-05-12 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
US6987090B2 (en) * 2002-05-09 2006-01-17 Lg Household & Health Care Ltd. Use of 3-position cyclosporin derivatives for hair growth
JP2006524232A (ja) 2003-03-17 2006-10-26 アルバニー モレキュラー リサーチ インコーポレーティッド 新規サイクロスポリン
GB0320638D0 (en) 2003-09-03 2003-10-01 Novartis Ag Organic compounds
JP2008514701A (ja) 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキン類似体およびそれらの薬学的使用
EP1804823A4 (en) 2004-09-29 2010-06-09 Amr Technology Inc NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS
JP5139065B2 (ja) * 2004-10-01 2013-02-06 スシネキス インク C型肝炎感染の治療及び予防のための3−エーテル及び3−チオエーテル置換シクロスポリン誘導体
US7196161B2 (en) * 2004-10-01 2007-03-27 Scynexis Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
UA88484C2 (ru) 2004-10-01 2009-10-26 Дебиофарм Са ПРИМЕНЕНИЕ [D-MeAla]3-[EtVal]4-ЦИКЛОСПОРИНА ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИИ ГЕПАТИТА С И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, КОТОРАЯ ВКЛЮЧАЕТ [D-MeAla]3-[EtVal]4-ЦИКЛОСПОРИН
US7361636B2 (en) 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
WO2006071618A1 (en) * 2004-12-23 2006-07-06 Novartis Ag Compounds for flaviviridae treatment
CA2587793A1 (en) * 2004-12-23 2006-07-06 Novartis Ag Compositions for hcv treatment
US8329658B2 (en) * 2005-09-30 2012-12-11 Scynexis, Inc. Arylalkyl and heteroarylalkyl derivatives of cyclosporine A for the treatment and prevention of viral infection
BRPI0616476A2 (pt) * 2005-09-30 2011-06-21 Scynexis Inc uso de uma quantidade terapeuticamente eficaz de um derivado de ciclosporina, e, composição farmacêutica
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
ATE502633T1 (de) 2006-05-19 2011-04-15 Scynexis Inc Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
EP2027761A1 (fr) * 2006-06-02 2009-02-25 Claude Annie Perrichon Gestion des electrons actifs
BRPI0719189A2 (pt) * 2006-10-12 2018-08-14 Univ Kyushu Nat Univ Corp uso de ciclosporinas modificadas
US7576057B2 (en) 2006-11-20 2009-08-18 Scynexis, Inc. Cyclic peptides
US20080255038A1 (en) * 2007-04-11 2008-10-16 Samuel Earl Hopkins Pharmaceutical compositions
WO2009042892A1 (en) 2007-09-26 2009-04-02 Oregon Health & Science University Cyclic undecapeptides and derivatives as multiple sclerosis therapies
US20090306033A1 (en) * 2008-06-06 2009-12-10 Keqiang Li Novel cyclic peptides
US9090671B2 (en) 2008-06-06 2015-07-28 Scynexis, Inc. Macrocyclic peptides
AU2009268549B2 (en) * 2008-07-10 2015-07-16 Allergan, Inc. Cyclosporin derivatives for treating ocular and dermal diseases and conditions
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
EP2376524B1 (en) 2008-12-31 2017-03-15 Cypralis Limited Derivatives of cyclosporin a
AU2010254316A1 (en) * 2009-05-27 2011-12-22 Allergan, Inc. Cyclosporin derivatives for treating inflammatory diseases and conditions
GB0912584D0 (en) * 2009-07-20 2009-08-26 Ucl Business Plc Cyclosporin conjugates
WO2012009715A2 (en) * 2010-07-16 2012-01-19 S&T Global Inc. Novel cyclosporin derivatives for the treatment and prevention of a viral infection
WO2012021796A2 (en) 2010-08-12 2012-02-16 S&T Global, Inc. Novel cyclosporin derivatives for the treatment and prevention of a viral infection
RU2013119869A (ru) 2010-10-12 2014-11-20 Аллерган, Инк. Аналоги циклоспорина
US9175042B2 (en) * 2010-10-12 2015-11-03 Allergan, Inc. Cyclosporin analogs
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
JP6144627B2 (ja) 2010-12-15 2017-06-07 コントラヴィア ファーマシューティカルズ、インク. アミノ酸1および3で修飾されたシクロスポリン類似体分子
EP2705856A1 (en) 2012-09-07 2014-03-12 Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. Compounds for the treatment of neurodegenerative disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
US4814323A (en) * 1986-03-25 1989-03-21 Andrieu J M Process for the treatment and the prevention of AIDS and other disorders induced by the LAV/HTLV III virus
ATE148469T1 (de) * 1990-11-02 1997-02-15 Sandoz Ag Zyklosporine
PL324531A1 (en) * 1995-07-17 1998-06-08 Chem Ag C Derivatives of cyclosporin effective against hiv virus

Also Published As

Publication number Publication date
MA26459A1 (fr) 2004-12-20
TNSN97211A1 (fr) 2005-03-15
US5965527A (en) 1999-10-12
EP0948527B1 (fr) 2002-06-05
AU5669298A (en) 1998-07-17
WO1998028329A1 (fr) 1998-07-02
JP2001507346A (ja) 2001-06-05
ATE218580T1 (de) 2002-06-15
DE69713148D1 (de) 2002-07-11
ZA9711606B (en) 1998-06-25
DK0948527T3 (da) 2002-09-16
EP0948527A1 (fr) 1999-10-13
JP4172822B2 (ja) 2008-10-29
PT948527E (pt) 2002-11-29
FR2757522B1 (fr) 1999-01-29
FR2757522A1 (fr) 1998-06-26

Similar Documents

Publication Publication Date Title
PT948527E (pt) Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem
PT951474E (pt) Novos derivados da ciclosporina sua preparacao e composicoes farmaceuticas que os contem
ES2178036T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
PT979244E (pt) Derivados de ciclosporina, sua preparacao e composicoes farmaceuticas que os contem
BG103945A (bg) Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
CO4930259A1 (es) Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
BG100016A (bg) Нiv протеазни инхибитори във фармацевтични комбинации за лечение на спин
EA199901016A1 (ru) 9-оксим-производные эритромицина
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
DE69819539D1 (de) Antithrombotische mittel
DE69330601D1 (de) Serotoninergische ergolin derivate
YU6396A (sh) Kombinacija inhibitora hiv proteaze sa drugim jedinjenjima za terapiju hiv infekcija
NO983444D0 (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
SE9403137D0 (sv) Derivatives of carbohydrates and compositions containing them
DK0561882T3 (da) Hydroxamsyrederivater, som inhiberer lipoxygenase
AP9801235A0 (en) Erythromycin derivatives.
RU93058386A (ru) Противовирусная комбинация, содержащая неуклеозидный аналог, фармацевтическая композиция, способ лечения
DK0774969T3 (da) HIV-proteaseinhibitor kombination